IPO registrations (S-1, F-1) · Registrants
iSpecimen Inc.
- SEC CIK
- 1558569 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2020-11-19, last 2026-07-17; 6 initial registrations, 16 amendments
- Outcome
- Final prospectus filed 2021-06-21; declared effective 2021-06-16
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 8 CABOT ROAD, SUITE 1800, Woburn, MA 08101
- EIN
- 27-0480143
- Ticker
- ISPC (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- iSpecimen Inc. on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2021-05-27)
- Final price
- $8.00 per share, within the range (424B4 filed 2021-06-21, an initial public offering)
- Shares sold
- 2,250,000
- Gross proceeds
- $18,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ISPC
- Lead underwriters
- ThinkEquity; ThinkEquity, a division of Fordham Financial Management, Inc (2,250,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ISPECIMEN, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ISPECIMEN Inc. Fuzzy (name and state)
- Business registration: ISPECIMEN INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ISPECIMEN INC. EXACT (EIN (EXACT))
- Federal award recipient: ISPECIMEN INC Fuzzy (name and state)
- Form D issuer: iSpecimen Inc. EXACT (CIK (EXACT))
- SEC filer: iSpecimen Inc. EXACT (CIK (EXACT))
- Person page: Joseph J Basile Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Theresa L Mock Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 37
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-11-19 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001104659-20-127325 ↗ |
| 2020-12-31 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-20-141041 ↗ |
| 2021-01-20 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-21-005820 ↗ |
| 2021-04-02 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-21-046101 ↗ |
| 2021-04-27 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-21-055687 ↗ |
| 2021-05-13 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-21-065952 ↗ |
| 2021-05-27 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001104659-21-073219 ↗ |
| 2021-06-16 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-21-002359 ↗ |
| 2021-06-21 | 424B4 | 424B4 (final prospectus) | iSpecimen Inc. | 0001104659-21-082856 ↗ |
| 2021-12-14 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001104659-21-149560 ↗ |
| 2021-12-23 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-21-004815 ↗ |
| 2022-06-06 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-22-001695 ↗ |
| 2022-07-12 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-22-002041 ↗ |
| 2022-08-05 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-22-002278 ↗ |
| 2024-10-18 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001104659-24-109912 ↗ |
| 2024-10-29 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-24-003308 ↗ |
| 2024-10-31 | 424B4 | 424B4 (final prospectus) | iSpecimen Inc. | 0001104659-24-112853 ↗ |
| 2025-05-02 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001213900-25-039321 ↗ |
| 2025-05-23 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-047292 ↗ |
| 2025-06-11 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-053464 ↗ |
| 2025-06-27 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-059036 ↗ |
| 2025-07-08 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-062116 ↗ |
| 2025-07-23 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-25-002324 ↗ |
| 2025-07-25 | 424B4 | 424B4 (final prospectus) | iSpecimen Inc. | 0001213900-25-067485 ↗ |
| 2025-08-20 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001213900-25-078951 ↗ |
| 2025-08-25 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-080408 ↗ |
| 2025-09-08 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-085541 ↗ |
| 2025-10-06 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-096648 ↗ |
| 2025-12-19 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-25-123930 ↗ |
| 2025-12-29 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-25-003930 ↗ |
| 2026-01-30 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-26-000417 ↗ |
| 2026-06-17 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-26-002047 ↗ |
| 2026-06-24 | S-1 | S-1 (registration) | iSpecimen Inc. | 0001213900-26-071550 ↗ |
| 2026-07-06 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-26-075593 ↗ |
| 2026-07-17 | S-1/A | S-1/A (amendment) | iSpecimen Inc. | 0001213900-26-078869 ↗ |
| 2026-07-30 | EFFECT | EFFECT (declared effective) | iSpecimen Inc. | 9999999995-26-002496 ↗ |
| 2026-08-07 | 424B4 | 424B4 (final prospectus) | iSpecimen Inc. | 0001213900-26-086434 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-05-27 | S-1/A | registration statement | $8.00–$10.00 | 2,222,222 | - | Nasdaq ISPC | 1 | primary document; range, shares headline, cover names 1 | document ↗ | |
| 2021-06-21 | 424B4 | final prospectus | $8.00 | 2,250,000 | $18,000,000 | Nasdaq ISPC | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bielak Benjamin | Officer | Chief Info Officer & Secretary; Chief Information Officer | 5 | 2021–2023 | |
| Curley Tracy | Director,Officer; Officer | CEO, CFO and Treasurer; CFO and Treasurer; CFO & Treasurer; Chief Financial Officer; Interim CEO, CFO and Treasurer | 6 | 2021–2023 | |
| Lawrence Margaret H. | Director | 3 | 2021–2023 | ||
| Brooks John L | Director | 6 | 2021–2024 | ||
| Gullans Steven R. Ph.D. | Director | 6 | 2021–2024 | ||
| Ianelli Christopher | Director; Director,Officer | CEO and President; CEO, President; President & CEO | 8 | 2021–2023 | |
| Mullan Jill | Director; Director,Officer | COO and Secretary; COO & Secretary; COO, Secretary, Treasurer | 9 | 2021–2023 | |
| OBF Investments, LLC | TenPercentOwner | 2 | 2021 | ||
| Ross Andrew L. | Director; Director,TenPercentOwner | 7 | 2021–2024 | ||
| Scholl George H. | Director; Director,TenPercentOwner | 5 | 2021–2023 | ||
| Basile Joseph J. | Director | 3 | 2022–2023 | person page Fuzzy | |
| Mock Theresa L | Director | 2 | 2024 | person page Fuzzy | |
| Graham Elizabeth Ames | Director | 2 | 2024 | ||
| Field Katharyn | Director | 2 | 2024 | ||
| Paolone Richard | Director | 2 | 2024 | ||
| Dhaliwal Avtar | Director | 2 | 2024 | ||
| LIM ROBERT BRADLEY | Director,Officer | Chief Executive Officer | 1 | 2024 | |
| Liang Yuying | Officer | Chief Financial Officer | 1 | 2025 | |
| Lee Arphing | Director | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-05-14 | iSpecimen Inc. | Other | $2,500,000 | $2,500,000 | 2 | 1 |
| 2026-01-05 | iSpecimen Inc. | Other | $5,500,000 | $5,500,000 | 3 | 1 |
| 2025-08-06 | iSpecimen Inc. | Other | $1,750,000 | $1,750,000 | 4 | 1 |
| 2021-12-09 | iSpecimen Inc. | Other Health Care | $20,999,988 | $20,999,988 | 4 | 1 |
| 2018-08-16 | iSpecimen Inc. | Other Health Care | $4,000,000 | $800,000 | 3 | 1 |
| 2017-03-29 | iSpecimen Inc. | Other Health Care | $5,500,000 | $500,000 | 1 | 1 |
| 2014-09-05 | iSpecimen Inc. | Other Health Care | $8,561,041 | $8,561,041 | 13 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ISPECIMEN Inc. | MA | State business registries | name and state |
| Business registration | ISPECIMEN INC. | MA | State business registries | name and state |
| Business registration | ISPECIMEN, INC. | MA | State business registries | name and state |
| Plan sponsor | ISPECIMEN INC. | MA | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | ISPECIMEN INC | MA | Federal spending (USAspending) | name and state |
| Form D issuer | iSpecimen Inc. | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | iSpecimen Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | iSpecimen Inc. | MA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ISPECIMEN INC. | EIN (EXACT) | ||
| Person page | Joseph J Basile | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Theresa L Mock | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, MA first:
- CURAGEN CORP MA
- VARIAGENICS INC MA
- VIACELL INC MA
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. MA
- VIACELL INC MA
- AMR RESEARCH INC MA
- PAREXEL INTERNATIONAL CORP MA
- DYAX CORP MA
- PHYTERA INC MA
- WEED, INC. AZ
In other datasets, the same topic (Medical research) in MA:
- Nonprofit: ACADEMY FOR HEALTH & LIFESPAN RESEARCH INC (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research